| ALBUTEROL SULFATE | GlaxoSmithkline | ||
| EQ 0.09MG BASE/INH ; AEROSOL,METERED |
Less Than $1000 mn
|
||
| None | None | ||
|
More Than 5
|
None | ||
| None | None | ||
| VENTOLIN HFA is a beta2-adrenergic agonist indicated for: • Treatment or prevention of bronchospasm in adult and pediatric patients aged 4 years and older with reversible obstructive airway disease. • Prevention of exercise-induced bronchospasm in adult and pediatric patients aged 4 years and older. | |||
|
Yes
| |||
| VENTOLIN HFA | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 | Patent 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||||
| ************** ******* *********** ********** * *********** **********, * ********** *** ************* **** ** * ********** | ******* ********* *** * ****** *** ******* *** ************** ** * ************* ****** ** * **************** ****** ******* | ******* **** ******* *** ********* | ******* **** ******* *** ********* | ******** ********** ******** *********** ********** *** ***************** | ***** *** ******* ********* | ***** *** ******* ********* | ***** *** ******* ********* | ***** *** ******* ********* | ********** ****** | ******** ****** *** * ********** *** ****** *** *** ******** ******* | ********** ****** | ********** ****** | ********** ****** | ********* **** *****' ******* | ********* **** *****′ ******* | ***** *** ******* ********* | ****** ******* *** ** ******* ********* | ********** ******* ************ | ********* ********* *** * ********** ****** | ********* ********* *** * ********** ****** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|